BRIAN DUGAN: Open Payments
NPI 1669897211 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$451 in 27 payments from 13 companies in 2025. Trend: 2023 $704 · 2024 $734 · 2025 $451
Food & beverage: $451
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 5 | $109 |
| AstraZeneca Pharmaceuticals LP | 2 | $49 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $47 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 6 | $35 |
| WATERMARK MEDICAL, INC. | 2 | $35 |
| Novartis Pharmaceuticals Corporation | 2 | $34 |
| Alnylam Pharmaceuticals Inc. | 2 | $33 |
| Inspire Medical Systems, Inc. | 1 | $22 |
| Abbott Laboratories | 1 | $21 |
| Boston Scientific Corporation | 1 | $20 |
Products named: INJECTAFER, WAINUA, JARDIANCE, LifeVest, ARES 620 UNICORDER, LEQVIO, ONPATTRO, INSPIRE.
Industry payments across PA — which companies pay providers there.
